171 related articles for article (PubMed ID: 2829358)
21. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
Yagi M; Kato S; Kobayashi Y; Kubo K; Oyama S; Shimizu T; Nishitoba T; Isoe T; Nakamura K; Ohashi H; Kobayashi N; Iinuma N; Osawa T; Onose R; Osada H
Exp Cell Res; 1997 Aug; 234(2):285-92. PubMed ID: 9260896
[TBL] [Abstract][Full Text] [Related]
22. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
23. A v-sis oncogene protein produced in bacteria competes for platelet-derived growth factor binding to its receptor.
Wang JY; Williams LT
J Biol Chem; 1984 Sep; 259(17):10645-8. PubMed ID: 6088510
[TBL] [Abstract][Full Text] [Related]
24. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
Boensch C; Huang SS; Connolly DT; Huang JS
J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
[TBL] [Abstract][Full Text] [Related]
25. Opposing effects of a ras oncogene on growth factor-stimulated phosphoinositide hydrolysis: desensitization to platelet-derived growth factor and enhanced sensitivity to bradykinin.
Parries G; Hoebel R; Racker E
Proc Natl Acad Sci U S A; 1987 May; 84(9):2648-52. PubMed ID: 2883654
[TBL] [Abstract][Full Text] [Related]
26. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein.
Petti L; Nilson LA; DiMaio D
EMBO J; 1991 Apr; 10(4):845-55. PubMed ID: 1849073
[TBL] [Abstract][Full Text] [Related]
27. Platelet-derived growth factor agonist activity of a secreted form of the v-sis oncogene product.
Johnsson A; Betsholtz C; von der Helm K; Heldin CH; Westermark B
Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1721-5. PubMed ID: 2984666
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor: mechanism of action and relation to oncogenes.
Heldin CH; Betsholtz C; Johnsson A; Nistér M; Ek B; Rönnstrand L; Wasteson A; Westermark B
J Cell Sci Suppl; 1985; 3():65-76. PubMed ID: 3011826
[TBL] [Abstract][Full Text] [Related]
29. v-erbA oncogene induces invasiveness and anchorage-independent growth in cultured glial cells by mechanisms involving platelet-derived growth factor.
Llanos S; Iglesias T; Riese HH; Garrido T; Caelles C; Muñoz A
Cell Growth Differ; 1996 Mar; 7(3):373-82. PubMed ID: 8838867
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
31. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
32. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
[TBL] [Abstract][Full Text] [Related]
33. Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF BB.
Badache A; De Vries GH
J Cell Physiol; 1998 Nov; 177(2):334-42. PubMed ID: 9766530
[TBL] [Abstract][Full Text] [Related]
34. Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth.
Goustin AS; Betsholtz C; Pfeifer-Ohlsson S; Persson H; Rydnert J; Bywater M; Holmgren G; Heldin CH; Westermark B; Ohlsson R
Cell; 1985 May; 41(1):301-12. PubMed ID: 2986848
[TBL] [Abstract][Full Text] [Related]
35. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.
Leof EB; Proper JA; Goustin AS; Shipley GD; DiCorleto PE; Moses HL
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2453-7. PubMed ID: 3010310
[TBL] [Abstract][Full Text] [Related]
36. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance.
Maxwell M; Naber SP; Wolfe HJ; Galanopoulos T; Hedley-Whyte ET; Black PM; Antoniades HN
J Clin Invest; 1990 Jul; 86(1):131-40. PubMed ID: 2164040
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
38. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
Paasinen-Sohns A; Hölttä E
Oncogene; 1997 Oct; 15(16):1953-66. PubMed ID: 9365242
[TBL] [Abstract][Full Text] [Related]
39. NIH 3T3 cells transfected with a yeast H(+)-ATPase have altered sensitivity to insulin, insulin growth factor-I, and platelet-derived growth factor-AA.
Peterson EP; Martinez GM; Martinez-Zaguilan R; Perona R; Gillies RJ
J Cell Physiol; 1994 Jun; 159(3):551-60. PubMed ID: 8188769
[TBL] [Abstract][Full Text] [Related]
40. Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor.
Leal F; Williams LT; Robbins KC; Aaronson SA
Science; 1985 Oct; 230(4723):327-30. PubMed ID: 2996133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
